PBA
SRRK icon

Paradigm Biocapital Advisors’s Scholar Rock SRRK Stock Holding History

Paradigm Biocapital Advisors’s Portfolio SRRK Stock Details SRRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,226,080
Closed -$60.3M – 36
2026
Q1 		$60.3M Sell
1,226,080
-1,836,077
-60% -$82.3M 1.23% 23
2025
Q4 		$135M Buy
3,062,157
+1,052,412
+52% +$39.5M 3.44% 12
2025
Q3 		$74.8M Buy
2,009,745
+409,191
+26% +$14.3M 2.13% 15
2025
Q2 		$56.7M Buy
+1,600,554
New +$50.2M 2.42% 13
2025
Q1 		– Sell
-400,000
Closed -$17.3M – 31
2024
Q4 		$17.3M Buy
+400,000
New +$13M 0.6% 26

Other funds holding SRRK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Paradigm Biocapital Advisors's SRRK Position: Q2 2026 in Review

Paradigm Biocapital Advisors sold out of Scholar Rock (SRRK) in Q2 2026, closing a stake of 1,226,080 shares — an estimated $60.3M sold.

Paradigm Biocapital Advisors first reported a position in SRRK in Q4 2024 and held it in 5 quarters. The position peaked at $135M in Q4 2025. 305 funds tracked by Wall St. Rank hold SRRK as of Q2 2026.

  • Paradigm Biocapital Advisors reported no remaining Scholar Rock position as of Q2 2026 after selling out during the quarter.
  • Paradigm Biocapital Advisors sold 1,226,080 Scholar Rock shares in Q2 2026, an estimated $60.3M.
  • Paradigm Biocapital Advisors first reported a position in Scholar Rock in Q4 2024 and held it in 5 quarters.
  • Paradigm Biocapital Advisors's Scholar Rock position peaked at $135M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Scholar Rock as of Q2 2026.

Based on Paradigm Biocapital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.